<DOC>
	<DOCNO>NCT00262236</DOCNO>
	<brief_summary>This study people diagnose hypertension compare safety effectiveness aliskiren alone combination atenolol . Each patient study 12 week .</brief_summary>
	<brief_title>Efficacy Safety Aliskiren Atenolol Adults ( &gt; 18 ) With Mild Moderate Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<criteria>1 . Outpatients 18 year age old . 2 . Patients essential hypertension . Severe hypertension , Current diagnosis heart failure , History evidence secondary form hypertension , Participation investigational drug study within one month plan participation , Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hypertension , Aliskiren , Atenolol , Blood Pressure</keyword>
</DOC>